- Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study2010 | 2. lékařská fakulta
- ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma2021 | Lékařská fakulta v Hradci Králové, Ústřední knihovna
- Quantum phase transmitions studied within the interacting boson model2000 | Matematicko-fyzikální fakulta
- Nuclear shape-phase transitions studied within the interacting boson model-11999 | Publikace bez příslušnosti k fakultě
- Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer2009 | 3. lékařská fakulta
- Phase transformation study of AA 8006 stripcast alloy1999 | Matematicko-fyzikální fakulta
- A phase 1 study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer2006 | 1. lékařská fakulta
- A phase 1 study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer2006 | Fakulta tělesné výchovy a sportu
- Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer2007 | Lékařská fakulta v Plzni
- Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer2007 | 1. lékařská fakulta
- Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer2007 | Fakulta tělesné výchovy a sportu
- Randomizovaná, placebem kontrolovaná studie fáze II vandetanib plus docetaxel u předléčeného nemalobuněčného karcinomu plic.2007 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)2005 | 3. lékařská fakulta
- A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis2018 | 1. lékařská fakulta
- Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study2015 | Lékařská fakulta v Hradci Králové
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis2012 | 2. lékařská fakulta
- Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study2019 | 1. lékařská fakulta
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study2023 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis2012 | 1. lékařská fakulta
- Pemetrexed and cyclophospadmide in patients with locally advaced or metastatic breast cancer: A phase I study2003 | 1. lékařská fakulta
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis A phase 2 study2014 | 1. lékařská fakulta
- High dose accelerated radiotherapy for inoperable squamous lung cancer - A phase II study2006 | 3. lékařská fakulta
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS2018 | 1. lékařská fakulta
- A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab2021 | 1. lékařská fakulta
- Gemcitabine in locally advanced and metastatic non-small cell lung cancer: The Central European phase II study1998 | 3. lékařská fakulta
- A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)2021 | 2. lékařská fakulta
- A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis2005 | 1. lékařská fakulta
- A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis2005 | Fakulta tělesné výchovy a sportu
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study2023 | 1. lékařská fakulta
- A randomized phase II study with concurrent versus sequential radiochemotherapy in non-small cell lung cancerPublikace bez příslušnosti k fakultě
